Fred Alger Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Fred Alger Management's MRNA Position: Q3 2026 in Review
Fred Alger Management increased its Moderna (MRNA) stake by 33% in Q3 2026, buying an estimated $761K and bringing the position to 28,494 shares worth $5.49M. The position accounts for 0.02% of the portfolio, ranked #237.
Fred Alger Management first reported a position in MRNA in Q1 2019 and has held it in 12 quarters since. The position peaked at $36.7M in Q4 2022. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Fred Alger Management held 28,494 shares of Moderna worth $5.49M as of Q3 2026.
- Fred Alger Management bought 7,059 Moderna shares in Q3 2026, an estimated $761K.
- Moderna made up 0.02% of Fred Alger Management's portfolio in Q3 2026, its #237 holding.
- Fred Alger Management first reported a position in Moderna in Q1 2019 and has held it in 12 quarters since.
- Fred Alger Management's Moderna position peaked at $36.7M in Q4 2022.
- 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Fred Alger Management's 13F filing for Q3 2026, filed 16 Nov 2026.